Cargando…
MicroRNA-181 as a prognostic biomarker for survival in acute myeloid leukemia: a meta-analysis
Accumulating evidence has indicated that microRNA-181 (miR-181) is dysregulated in hematological malignancies, and associates with the clinical outcomes. However, the association of miR-181 expression levels with acute myeloid leukemia (AML) remains inconclusive, as publications from different group...
Autores principales: | Guo, Qiang, Luan, Junwen, Li, Ni, Zhang, Zhen, Zhu, Xiaoxiao, Zhao, Lin, Wei, Ran, Sun, Linlin, Shi, Yin, Yin, Xunqiang, Ding, Na, Jiang, Guosheng, Li, Xia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5687675/ https://www.ncbi.nlm.nih.gov/pubmed/29179505 http://dx.doi.org/10.18632/oncotarget.19195 |
Ejemplares similares
-
Meta-analysis of the Prognostic Value of microRNA-22 in Leukemia Patients
por: Xia, Jing, et al.
Publicado: (2023) -
The Potential Diagnostic Accuracy of Circulating MicroRNAs for Leukemia: A Meta-Analysis
por: Zhang, Wen-Ting, et al.
Publicado: (2021) -
Dysregulation of microRNA in cholangiocarcinoma identified through a meta-analysis of microRNA profiling
por: Likhitrattanapisal, Somsak, et al.
Publicado: (2020) -
A comprehensive analysis of microRNAs as diagnostic biomarkers for asthma
por: Xu, Li, et al.
Publicado: (2020) -
Diagnostic value of circulating microRNAs for liver cirrhosis: a meta-analysis
por: Guo, Liwei, et al.
Publicado: (2017)